Foresight Autonomous (FRSX) director discloses shares, options and RSUs
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Foresight Autonomous Holdings Ltd. director Raz-Avayo Vered filed an initial statement of beneficial ownership. Vered directly holds 150,000 Ordinary Shares and stock options covering 42,857, 21,429 and 57,143 Ordinary Shares, each with an exercise price of $1.1200 per share.
The options expire on August 27, 2026, September 23, 2026 and October 20, 2029 and are fully vested. Vered also has 75,000 Ordinary Shares issuable upon vesting of restricted share units through July 1, 2027. The company’s securities are also listed as ADSs, where one ADS represents 90 Ordinary Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Raz-Avayo Vered
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 42,857 shares (Direct);
Ordinary Shares — 150,000 shares (Direct)
Footnotes (1)
- Includes 75,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027. Each RSU represents the right to receive one Ordinary Share. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on August 27,2017 and fully vested as of July 16, 2020. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on September 23 ,2019 and fully vested as of July 31, 2022. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on October 20 ,2022 and fully vested as of September 30,2025.
Key Figures
Direct Ordinary Shares: 150,000 shares
Option Underlying Shares (2026-08-27): 42,857 shares
Option Underlying Shares (2026-09-23): 21,429 shares
+4 more
7 metrics
Direct Ordinary Shares
150,000 shares
Directly held by Raz-Avayo Vered
Option Underlying Shares (2026-08-27)
42,857 shares
Stock options, exercise price $1.1200, expiration August 27, 2026
Option Underlying Shares (2026-09-23)
21,429 shares
Stock options, exercise price $1.1200, expiration September 23, 2026
Option Underlying Shares (2029-10-20)
57,143 shares
Stock options, exercise price $1.1200, expiration October 20, 2029
Option Exercise Price
$1.1200 per share
Converted from NIS 3.50 using 3.119 ratio as of March 16, 2026
RSUs Outstanding
75,000 shares
Ordinary Shares issuable upon RSU vesting through July 1, 2027
ADS to Ordinary Share Ratio
1 ADS = 90 Ordinary Shares
ADS structure for issuer’s securities, convertible at holder’s election
Key Terms
restricted share units ("RSUs"), American Depository Shares ("ADS"), exercise price, fully vested, +1 more
5 terms
exercise price financial
"The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
fully vested financial
"The options were granted on October 20 ,2022 and fully vested as of September 30,2025."
expiration date financial
"The ADSs have no expiration date."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What does Foresight Autonomous (FRSX) director Raz-Avayo Vered report owning?
Raz-Avayo Vered reports direct ownership of 150,000 Ordinary Shares plus vested stock options over additional shares. The filing also shows 75,000 Ordinary Shares issuable from RSUs that vest through July 1, 2027, indicating equity-based compensation exposure.
How many stock options does Raz-Avayo Vered hold in FRSX and at what price?
Vered holds stock options over 42,857, 21,429 and 57,143 Ordinary Shares. Each grant carries an exercise price of $1.1200 per share, converted from a NIS 3.50 grant price based on a stated 3.119 ratio as of March 16, 2026.
When do Raz-Avayo Vered’s Foresight Autonomous stock options expire?
The options held by Vered expire on August 27, 2026, September 23, 2026 and October 20, 2029. Footnotes state these options were granted in 2017, 2019 and 2022 and were fully vested by 2020, 2022 and 2025, respectively.
What RSU holdings does Raz-Avayo Vered have in Foresight Autonomous (FRSX)?
Vered holds restricted share units representing 75,000 Ordinary Shares, scheduled to vest through July 1, 2027. Each RSU converts into one Ordinary Share upon vesting, adding to Vered’s potential future share ownership beyond currently held shares and options.
Is Raz-Avayo Vered’s Form 3 for FRSX reporting a transaction or just holdings?
This Form 3 functions as an initial statement of beneficial ownership, listing Vered’s existing holdings and derivative positions. The transactions are coded as holdings, with no buy or sell activity indicated, so it mainly documents the current equity position in the company.